Guardian Pharmacy Services, Inc. GRDN
Set alert
40.69 USD +0.24 +0.59%
At close · Oct 30
40.69 0.00 0.00%
After hours · Oct 30, 4:01 PM ET
40.26 Day range 41.37
27.03 52-week range 48.00
- YTD
- +35.23%
- 1 year
- +43.68%
- Open
- 40.98
- Prev close
- 40.45
- Mkt cap
- 2.58B
- Vol
- 318.98K
- Avg vol
- 496.20K
- EPS
- 1.03
- P/E
- 39.50
- Div yield
- 0.00%
More statistics
- Low
- 40.26
- High
- 41.37
- Forward P/E
- 28.27
- Beta
- 0.02
- Short ratio
- 3.76
- Inst. own
- 60.88%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 40.99
- 200-d avg
- 38.03
- 1y target
- 49.86
2Y chart
Events in this range
- Aug 11, 2025Earnings: 0.23; estimate 0.22; surprise 4.55%
- Nov 10, 2025Earnings: 0.25; estimate 0.24; surprise 4.17%
- Mar 11, 2026Earnings: 0.37; estimate 0.27; surprise 37.04%
- May 6, 2026Earnings: 0.29; estimate 0.24; surprise 20.83%
- May 7, 2026Rating: Oppenheimer · Outperform → Outperform
- Jun 17, 2026Rating: B of A Securities · Buy → Buy
- Jun 17, 2026Rating: Truist Securities · Buy → Buy
- Aug 6, 2026Earnings: 0.29; estimate 0.2617; surprise 10.81%
- Aug 7, 2026Rating: Oppenheimer · Outperform → Outperform
- Sep 21, 2026Rating: Truist Securities · Buy → Buy
- Sep 23, 2026Rating: Keybanc · — → Overweight
Signals (83)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 29, 2026 | 2 days ago |
| SMA: Bearish | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 12, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 24, 2026 | 1 month ago |
| RSI: Overbought | Sep 14, 2026 | 1 month ago |
| RSI: Overbought | Sep 10, 2026 | 1 month ago |
| SMA: Bullish | Sep 3, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| SMA: Bearish | Aug 4, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 2 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 31, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 28, 2026 | 3 months ago |
| SMA: Bullish | Jul 24, 2026 | 3 months ago |
| SMA: Bearish | Jul 22, 2026 | 3 months ago |
| SMA: Bullish | Jun 25, 2026 | 4 months ago |
| SMA: Bearish | Jun 24, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 23, 2026 | 4 months ago |
| RSI: Overbought | Jun 17, 2026 | 4 months ago |
| RSI: Overbought | Jun 9, 2026 | 4 months ago |
| SMA: Bullish | May 20, 2026 | 5 months ago |
| MACD: Buy Signal | May 20, 2026 | 5 months ago |
| SMA: Bearish | May 18, 2026 | 5 months ago |
| SMA: Bullish | May 15, 2026 | 5 months ago |
| SMA: Bearish | May 8, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 15, 2026 | 6 months ago |
| RSI: Overbought | Apr 9, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 19, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 6, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 4, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 23, 2026 | 8 months ago |
| MACD: Buy Signal | Jan 29, 2026 | 9 months ago |
| SMA: Bullish | Jan 28, 2026 | 9 months ago |
| SMA: Bearish | Jan 27, 2026 | 9 months ago |
| SMA: Bullish | Jan 22, 2026 | 9 months ago |
| SMA: Bearish | Jan 15, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 29, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 11, 2025 | 10 months ago |
| MACD: Sell Signal | Nov 17, 2025 | 11 months ago |
| RSI: Overbought | Nov 11, 2025 | 11 months ago |
| RSI: Overbought | Oct 24, 2025 | 1 year ago |
| SMA: Bullish | Oct 20, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 17, 2025 | 1 year ago |
| SMA: Bearish | Oct 1, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 16, 2025 | 1 year ago |
| RSI: Overbought | Aug 28, 2025 | 1 year ago |
| RSI: Overbought | Aug 18, 2025 | 1 year ago |
| RSI: Overbought | Aug 14, 2025 | 1 year ago |
| SMA: Bullish | Aug 12, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 12, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 8, 2025 | 1 year ago |
| SMA: Bearish | Aug 7, 2025 | 1 year ago |
| SMA: Bullish | Aug 5, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 23, 2025 | 1 year ago |
| SMA: Bearish | May 21, 2025 | 1 year ago |
| MACD: Sell Signal | May 13, 2025 | 1 year ago |
| RSI: Overbought | May 2, 2025 | 1 year ago |
| SMA: Bullish | Apr 9, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 9, 2025 | 1 year ago |
| SMA: Bearish | Apr 8, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 8, 2025 | 1 year ago |
| SMA: Bullish | Mar 31, 2025 | 1 year ago |
| SMA: Bearish | Mar 28, 2025 | 1 year ago |
| SMA: Bullish | Mar 27, 2025 | 1 year ago |
| SMA: Bearish | Mar 25, 2025 | 1 year ago |
| SMA: Bullish | Mar 17, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 12, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 10, 2025 | 1 year ago |
| SMA: Bearish | Feb 6, 2025 | 1 year ago |
| SMA: Bullish | Feb 4, 2025 | 1 year ago |
| SMA: Bearish | Feb 3, 2025 | 1 year ago |
| SMA: Bullish | Jan 29, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 17, 2025 | 1 year ago |
| RSI: Overbought | Nov 21, 2024 | 1 year ago |
Key statistics
- Market cap
- 2.57B
- Enterprise value
- 2.52B
- Trailing P/E
- 39.36
- Forward P/E
- 28.27
- PEG ratio
- 0.00
- Price / sales
- 1.75
- Price / book
- 10.46
- EPS (TTM)
- 1.03
- Beta
- 0.02
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 4.50%
- Revenue (TTM)
- 1.46B
- Revenue growth
- 2.20%
- Free cash flow
- 64.55M
- Total cash
- 89.81M
- Total debt
- 39.27M
- Return on equity
- 30.42%
- Shares outstanding
- 63.32M
- Short % of float
- 4.71%
- 50-day average
- 40.99
- 200-day average
- 38.03
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 49.86 +22.5% upside
Now 40.69
- Target (low)
- 47.00
- Target (mean)
- 49.86
- Target (high)
- 52.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
- Strong buy1
- Buy6
- Hold0
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 0.31429.
Financials — quick view
GRDN Revenue — quarterly 351.77M
GRDN Net income — quarterly 21.87M
GRDN EPS — quarterly 0.35
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | 0.3146 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 0.2617 | 0.29 | +0.03 | +10.81% |
| May 6, 2026 | Mar 31, 2026 | 0.24 | 0.29 | +0.05 | +20.83% |
| Mar 11, 2026 | Dec 31, 2025 | 0.27 | 0.37 | +0.10 | +37.04% |
| Nov 10, 2025 | Sep 30, 2025 | 0.24 | 0.25 | +0.01 | +4.17% |
| Aug 11, 2025 | Jun 30, 2025 | 0.22 | 0.23 | +0.01 | +4.55% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 23, 2026 | Keybanc | init | — | Overweight |
| Sep 21, 2026 | Truist Securities | main | Buy | Buy |
| Aug 7, 2026 | Oppenheimer | main | Outperform | Outperform |
| Jun 17, 2026 | Truist Securities | main | Buy | Buy |
| Jun 17, 2026 | B of A Securities | main | Buy | Buy |
| May 7, 2026 | Oppenheimer | main | Outperform | Outperform |
About Guardian Pharmacy Services, Inc.
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- guardianpharmacy.com
News
- Guardian Pharmacy Services, Inc. to Report Third Quarter 2026 Financial Results and Host Conference Call
- Transcript: Guardian Pharmacy Service Q2 2026 Earnings Conference Call
- Bet on Winning DuPont Analysis & Pick 5 Top Stocks
- This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
- Keybanc Initiates Coverage On Guardian Pharmacy Service with Overweight Rating, Announces Price Target of $52
- Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $51
- Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Average Recommendation of “Moderate Buy” by Analysts
- Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy
- Guardian Pharmacy Services, Inc. $GRDN Shares Purchased by Bank of America Corp DE
- Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference
Your note
Sign in to keep a note on GRDN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ACKERMAN JOHN | Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Sep 24, 2026 | 0 |
| BINDLEY CAPITAL PARTNERS I, L.L.C | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Sep 24, 2026 | 16,669,700 |
| BINDLEY WILLIAM E | Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Sep 24, 2026 | 0 |
| BURKE FRED | Chief Executive Officer | Conversion of Exercise of derivative security | Sep 24, 2026 | 3,438,060 |
| CARDINAL EQUITY FUND L P | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Sep 24, 2026 | 1,287,240 |
| FORBES KENDALL | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Sep 24, 2026 | 1,651,060 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 6.51% | 3,241,612 | 131.43M | Jun 29, 2026 |
| Wellington Management Group, LLP | 3.47% | 1,729,032 | 70.10M | Jun 29, 2026 |
| Blackrock Inc. | 3.16% | 1,575,989 | 63.90M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 2.77% | 1,379,750 | 55.94M | Jun 29, 2026 |
| Woodline Partners LP | 2.62% | 1,306,340 | 52.97M | Jun 29, 2026 |
| Valiant Capital Management, L.P. | 2.38% | 1,186,658 | 48.11M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.06% | 1,028,313 | 41.69M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.65% | 820,410 | 33.26M | Sep 29, 2026 |
| Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund | 1.08% | 538,325 | 21.83M | Jul 30, 2026 |
| Putnam Funds Trust-PUTNAM CORE EQUITY FUND | 1.02% | 508,135 | 20.60M | Jul 30, 2026 |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 0.96% | 476,800 | 19.33M | Jul 30, 2026 |
| LOOMIS SAYLES FUNDS II-Loomis Sayles Small Cap Growth Fund | 0.95% | 470,706 | 19.08M | Jun 29, 2026 |